Milk Thistle Extract/high quality/CAS84604-20-6

Shandong Fengjin Beauty Biotech is a chemical company，a multi-grade raw material supplier for medicine, food and cosmetics. We sell HA, PGA, Recombinant collagen, EGT, Ceramides, Ectoine. ect. 
Dr. Zhu Xiqiang，the CEO of Fengjin Beauty Biotech is the first scientist in the world to discover that polyglutamic acid has a whitening mechanism. After several years of in-depth research on polyglutamic acid, several derivative raw materials have been developed for this ingredient. At the same time, under the leadership of Dr. Zhu Xiqiang, its R&D team has also made major breakthroughs in the fermentation and extraction process of collagen and PDRN.
You're welcome to contact with us about pharma and raw materials.

Function:

Milk thistle extract protects liver cells by blocking the entry of harmful toxins and helping to remove these substances from liver cells. Like other bioflavonoids, silymarin is a powerful antioxidant. Silymarin has also been shown to regenerate damaged liver cells. Recent studies have shown that silymarin has the ability to prevent fibrosis, a process that occurs in patients with inflammatory liver conditions secondary to diseases such as alcoholism and hepatitis that may eventually develop into cirrhosis. The most common use of milk thistle extract is to neutralize the harmful effects of alcohol on the liver. Double-blind trials have shown that it can help the liver of people who quit drinking alcohol return to a healthy state. Some trials suggest that milk thistle extract can improve quality of life and even give hepatitis patients hope. Milk thistle changes bile composition, potentially reducing the risk of gallstones. However, this efficacy still needs to be confirmed in human clinical trials. Milk thistle extract has been shown to protect the liver from the potentially harmful effects of drugs used to treat schizophrenia and other psychiatric disorders. However, a trial found that it does not protect the liver from the potentially harmful effects of the drug Cocknix (1.2.3.4-tetrahydro-9-aminoacridine hydrochloride), which is used to treat early-stage Alzheimer's disease. Influence.